Literature DB >> 21212066

Predicting the future of genetic risk prediction.

Nilanjan Chatterjee1, Ju-Hyun Park, Neil Caporaso, Mitchell H Gail.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21212066      PMCID: PMC5376095          DOI: 10.1158/1055-9965.EPI-10-1022

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  22 in total

Review 1.  Why have we failed to find the low penetrance genetic constituents of common cancers?

Authors:  Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

Review 2.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

3.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

Authors:  Sholom Wacholder; Stephen Chanock; Montserrat Garcia-Closas; Laure El Ghormli; Nathaniel Rothman
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

4.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

5.  Polygenes, risk prediction, and targeted prevention of breast cancer.

Authors:  Paul D P Pharoah; Antonis C Antoniou; Douglas F Easton; Bruce A J Ponder
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

6.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

7.  An expanded risk prediction model for lung cancer.

Authors:  Margaret R Spitz; Carol J Etzel; Qiong Dong; Christopher I Amos; Qingyi Wei; Xifeng Wu; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

8.  Using relative utility curves to evaluate risk prediction.

Authors:  Stuart G Baker; Nancy R Cook; Andrew Vickers; Barnett S Kramer
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-10-01       Impact factor: 2.483

9.  Projecting individualized probabilities of developing bladder cancer in white individuals.

Authors:  Xifeng Wu; Jie Lin; H Barton Grossman; Maosheng Huang; Jian Gu; Carol J Etzel; Christopher I Amos; Colin P Dinney; Margaret R Spitz
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

Review 10.  Missing heritability and strategies for finding the underlying causes of complex disease.

Authors:  Evan E Eichler; Jonathan Flint; Greg Gibson; Augustine Kong; Suzanne M Leal; Jason H Moore; Joseph H Nadeau
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

View more
  6 in total

1.  Genetic epidemiology with a capital E: where will we be in another 10 years?

Authors:  Duncan C Thomas
Journal:  Genet Epidemiol       Date:  2012-02-06       Impact factor: 2.135

2.  Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.

Authors:  Ju-Hyun Park; Mitchell H Gail; Mark H Greene; Nilanjan Chatterjee
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

3.  A weighted polygenic risk score using 14 known susceptibility variants to estimate risk and age onset of psoriasis in Han Chinese.

Authors:  Xianyong Yin; Hui Cheng; Yan Lin; Nathan E Wineinger; Fusheng Zhou; Yujun Sheng; Chao Yang; Pan Li; Feng Li; Changbing Shen; Sen Yang; Nicholas J Schork; Xuejun Zhang
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.

Authors:  Elena Tagliabue; Sara Gandini; Rino Bellocco; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Maria Teresa Landi; Chiara Menin; Maria Concetta Fargnoli; Jose Carlos García-Borrón; Jiali Han; Julian Little; Francesco Sera; Sara Raimondi
Journal:  Cancer Manag Res       Date:  2018-05-14       Impact factor: 3.989

5.  Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Authors:  Charmaine Pei Ling Lee; Astrid Irwanto; Agus Salim; Jian-min Yuan; Jianjun Liu; Woon Puay Koh; Mikael Hartman
Journal:  Breast Cancer Res       Date:  2014-06-18       Impact factor: 6.466

6.  Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.

Authors:  Lauren A Penn; Meng Qian; Enhan Zhang; Elise Ng; Yongzhao Shao; Marianne Berwick; DeAnn Lazovich; David Polsky
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.